Clinical trials
Completed Huntington Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
161 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 1 |
| 2004 | 4 |
| 2005 | 6 |
| 2006 | 3 |
| 2007 | 6 |
| 2008 | 4 |
| 2009 | 17 |
| 2010 | 3 |
| 2011 | 15 |
| 2012 | 5 |
| 2013 | 11 |
| 2014 | 7 |
| 2015 | 9 |
| 2016 | 4 |
| 2017 | 9 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 7 |
| 2021 | 10 |
| 2022 | 8 |
| 2023 | 2 |
| 2024 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 161 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 11 |
| Institut National de la Santé Et de la Recherche Médicale, France | 7 |
| Assistance Publique - Hôpitaux de Paris | 6 |
| CHDI Foundation, Inc. | 6 |
| Massachusetts General Hospital | 5 |
| Hoffmann-La Roche | 4 |
| Huntington Study Group | 4 |
| Prilenia | 4 |
| Siena Biotech S.p.A. | 4 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huntington Disease | 161 |
| Alzheimer Disease | 15 |
| Chorea | 15 |
| Parkinson Disease | 15 |
| Mental Disorders | 5 |
| Movement Disorders | 5 |
| Neurodegenerative Diseases | 5 |
| Cognitive Dysfunction | 4 |
| Amyotrophic Lateral Sclerosis | 3 |
| Basal Ganglia Diseases | 3 |
Trials
Showing 51 to 75 of 161. Each trial links to its page on Pharma Observatory.
61 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.